PSMA PET-guided radiation for high-risk prostate cancer
Part of Cancer clinical trials.
This trial tests a new way to plan radiation for high-risk prostate cancer. Doctors will use a special PET scan (PSMA PET) to find the main tumor inside the prostate and give it a stronger dose of radiation, along with standard hormone therapy. This approach might improve outcomes for patients with aggressive disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have high-risk prostate cancer that has not spread to distant organs, confirmed by biopsy within the last 6 months.
- You are scheduled to receive a specific type of radiation called SABR along with hormone therapy.
- You must have a PSMA PET scan showing a clear tumor in the prostate that can be targeted for a higher radiation dose.
- You have not had any prior surgery or radiation to treat your prostate cancer, except short-term hormone therapy (less than 3 months) if it was stopped at least 3 months ago.
- You agree to use effective birth control during and for 6 months after treatment if you are sexually active.
- You do not have severe urinary symptoms (AUA score of 18 or less) and your prostate is not too large (100 cc or less).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether combining standard hormone therapy and radiation with a special targeted radiation (PSMA-targeted radiotherapy) is safe and effective for men with high-risk prostate cancer that hasn't spread outside the pelvis.
This trial tests a combination of two treatments for men with prostate cancer that has spread to a small number of sites: a radioactive injection (177Lu-PSMA-617) that targets cancer cells, plus hormone-blocking medication. The goal is to control the cancer and delay progression.
This trial uses a special PET scan to find spots where prostate cancer has spread. Then, it delivers precise radiation to those spots while you receive standard hormone therapy. The goal is to see if this approach helps control the cancer.
This trial uses a special PET/MR scan to help doctors aim stereotactic radiation more precisely for certain higher-risk or unfavorable intermediate prostate cancers. It studies whether this targeted approach can safely treat the prostate (and specific areas needing extra treatment) without spreading to the body.
This trial tests whether using a special PSMA-PET scan to guide radiation therapy improves treatment for men with high-risk prostate cancer that hasn't spread. You would receive standard radiation plus hormone therapy, and the scan helps the doctor target the radiation more precisely.
This trial tests a special type of radiation therapy (SBRT) that delivers a higher dose directly to the main tumor in your prostate, guided by a PSMA PET scan. It aims to improve cancer control while limiting side effects.
Hear when a new Prostate Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.